Skip to content
CompanySight
Company No. 14533667 · Incorporated 9 Dec 2022

Bxta Nanotherapy Ltd

Registered name: BXTA NANOTHERAPY LTD

Part of Bxtaccelyon Group Limited group

Bxta Nanotherapy Ltd does not publish its revenue or profit. Its accounts to 30 Jun 2025 show net assets of £335k and 4 employees.

Bxta Nanotherapy Ltd did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 30 Jun 2025 showed net assets of £335k and 4 employees. The company is classified under “specialists medical practice activities” and is based in Slough; we hold 3 years of its filed accounts.

Balance sheet onlySection Q · Human health and social workSIC 86220Specialists medical practice activities
Status
Active
Location
Slough, South East
Age
3 yrs · since 2022
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “Seed Newco Limited”

Latest accounts · year to 30 Jun 2025

Key figures

Small team

Revenue not disclosed

Bxta Nanotherapy Ltd’s accounts for the year to 30 Jun 2025 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.

We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.

Employees
4
Net assets
£335k

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to30 Jun 202330 Jun 202430 Jun 2025
DisclosureNo P&LNo P&LNo P&L
Profit & loss
Revenue (turnover)———
Profit (best available)———
Employees (average)—44
Ratios
Profit margin———
Growth (year on year)
Headcount growth——0%
Balance sheet — indirect signals, not revenue
Cash at bank£240k£333k£80.7k
Net assets£116k£367k£335k
Current assets£287k£333k£147k
Debtors£46.8k£479£66.2k
SourceAccounts · bulk data Mar 2025Accounts · bulk data Mar 2025FilletedAccounts · bulk data Feb 2026
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
▼9%
Now £335k
Cash at bank
▼76%
Now £80.7k
Headcount
0%
Now 4
Deferred income
—
Now —
Fixed assets
—
Now —
Corporate ownership

Group structure

Ownership chain

  1. Bxtaccelyon Group Limitedultimate parent75–100%
  2. Seed Newco Limited75–100%
  3. Seed Bidco Limited75–100%
  4. Bxtaccelyon Limited75–100%
  5. Bxta Nanotherapy Ltdthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FilletedAccounts for the year to 30 Jun 2025, from the Companies House accounts bulk data published Feb 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.